Home › Epilepsy › Missouri › St. Louis
Epilepsy clinical trials in St. Louis, MO
5 studies for Epilepsy are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- Saint Louis University Medical School, St Louis
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- Washington University at St. Louis, St Louis
Diagnosing Epilepsy To EffeCT Change
Recruiting
- Washington University, St Louis
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RecruitingObservational study
- Washington University, St Louis
Amygdala Memory Enhancement
Recruiting
- Washington University School of Medicine, St Louis
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA18 studies
- Houston, TX15 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Durham, NC9 studies
- Phoenix, AZ9 studies
- Rochester, MN9 studies
- Cleveland, OH9 studies
- Miami, FL8 studies
- Birmingham, AL7 studies
- Mountain View, CA6 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.